Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment
- PMID: 36765592
- PMCID: PMC9913601
- DOI: 10.3390/cancers15030634
Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment
Abstract
Background: Due to recent changes in breast cancer treatment strategy, significantly more patients are treated with neoadjuvant systemic therapy (NST). Radiological methods do not precisely determine axillary lymph node status, with up to 30% of patients being misdiagnosed. Hence, supplementary methods for lymph node status assessment are needed. This study aimed to apply and evaluate machine learning models on clinicopathological data, with a focus on patients meeting NST criteria, for lymph node metastasis prediction.
Methods: From the total breast cancer patient data (n = 8381), 719 patients were identified as eligible for NST. Machine learning models were applied for the NST-criteria group and the total study population. Model explainability was obtained by calculating Shapley values.
Results: In the NST-criteria group, random forest achieved the highest performance (AUC: 0.793 [0.713, 0.865]), while in the total study population, XGBoost performed the best (AUC: 0.762 [0.726, 0.795]). Shapley values identified tumor size, Ki-67, and patient age as the most important predictors.
Conclusion: Tree-based models achieve a good performance in assessing lymph node status. Such models can lead to more accurate disease stage prediction and consecutively better treatment selection, especially for NST patients where radiological and clinical findings are often the only way of lymph node assessment.
Keywords: breast cancer; lymph node metastasis; machine learning; neoadjuvant systemic treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.EBioMedicine. 2021 Jul;69:103460. doi: 10.1016/j.ebiom.2021.103460. Epub 2021 Jul 4. EBioMedicine. 2021. PMID: 34233259 Free PMC article. Clinical Trial.
-
Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.Ann Surg Oncol. 2018 Jun;25(6):1512-1520. doi: 10.1245/s10434-018-6404-y. Epub 2018 Mar 6. Ann Surg Oncol. 2018. PMID: 29511992
-
Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).J Am Coll Surg. 2017 Apr;224(4):688-694. doi: 10.1016/j.jamcollsurg.2016.12.036. Epub 2017 Jan 13. J Am Coll Surg. 2017. PMID: 28089784 Free PMC article.
-
Diagnostic Performance of Noninvasive Imaging for Assessment of Axillary Response After Neoadjuvant Systemic Therapy in Clinically Node-positive Breast Cancer: A Systematic Review and Meta-analysis.Ann Surg. 2021 Apr 1;273(4):694-700. doi: 10.1097/SLA.0000000000004356. Ann Surg. 2021. PMID: 33201095
-
Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis.Ann Surg. 2019 Mar;269(3):432-442. doi: 10.1097/SLA.0000000000003075. Ann Surg. 2019. PMID: 30312200 Free PMC article.
Cited by
-
Predicting Radiation Esophagitis in Patients Undergoing Synchronous Boost Radiotherapy Post-Breast-Conserving Surgery.Dose Response. 2025 Apr 15;23(2):15593258251335802. doi: 10.1177/15593258251335802. eCollection 2025 Apr-Jun. Dose Response. 2025. PMID: 40297669 Free PMC article.
-
Editorial for the Special Issue "Breast Cancer-Therapeutic Challenges, Research Strategies and Novel Diagnostics".Cancers (Basel). 2023 Sep 18;15(18):4611. doi: 10.3390/cancers15184611. Cancers (Basel). 2023. PMID: 37760580 Free PMC article.
-
Predictive modeling of breast cancer-related lymphedema using machine learning algorithms.Gland Surg. 2024 Dec 31;13(12):2243-2252. doi: 10.21037/gs-24-252. Epub 2024 Dec 27. Gland Surg. 2024. PMID: 39822356 Free PMC article.
-
Advances in the application of computational pathology in diagnosis, immunomicroenvironment recognition, and immunotherapy evaluation of breast cancer: a narrative review.J Cancer Res Clin Oncol. 2023 Oct;149(13):12535-12542. doi: 10.1007/s00432-023-05002-8. Epub 2023 Jun 30. J Cancer Res Clin Oncol. 2023. PMID: 37389595 Free PMC article. Review.
-
The Role of AI in Breast Cancer Lymph Node Classification: A Comprehensive Review.Cancers (Basel). 2023 Apr 21;15(8):2400. doi: 10.3390/cancers15082400. Cancers (Basel). 2023. PMID: 37190328 Free PMC article. Review.
References
-
- Cancer Today. [(accessed on 10 October 2022.)]. Available online: https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&mode_....
-
- Centers for Disease Control and Prevention . Incidence and Relative Survival by Stage at Diagnosis for Common Cancers. USCS Data Brief, n.A., GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; Washington, DC, USA: 2021.
LinkOut - more resources
Full Text Sources